The pharmaceutical market is changing fast and industry has been required to move quickly to keep pace with this dynamic situation. By Randox Laboratories
While partnerships play an increasingly critical role in the drug development lifecycle, a poorly structured partnership can expose your intellectual property (IP) to considerable risk. By understanding six common sources of risk, you can take steps to protect your investment. By Jeff Spitzner, Rescentris
By Richard Lake, Pharmaceutical Market Development Manager, Restek
By Robertus van Miltenburg, Director of Marketing for qPCR and Nucleic Acid Preparation Systems for Roche Applied Science
By Gerd Maass, President and CEO of Roche NimbleGen